Karyopharm Therapeutics Inc.
KPTI
$8.38
-$0.17-1.99%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 38.95% | -11.26% | -26.08% | -35.66% | -18.58% |
| Total Receivables | -17.88% | -3.20% | -6.56% | 14.55% | -3.18% |
| Inventory | 1.82% | -20.55% | 4.68% | 0.63% | 1.43% |
| Prepaid Expenses | 14.45% | -2.70% | -19.80% | -16.01% | -16.96% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 14.93% | -8.30% | -18.60% | -23.15% | -15.31% |
|
|
|||||
| Total Current Assets | 14.93% | -8.30% | -18.60% | -23.15% | -15.31% |
| Net Property, Plant & Equipment | -3.12% | -9.82% | -8.17% | -7.72% | 103.96% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -63.30% | 0.00% | 0.60% | 0.12% | 1.95% |
| Total Assets | 12.66% | -8.24% | -17.88% | -22.33% | -13.22% |
|
|
|||||
| Total Accounts Payable | -25.76% | 107.62% | -55.77% | 14.98% | -11.69% |
| Total Accrued Expenses | -2.76% | 5.40% | 10.07% | -5.74% | 21.05% |
| Short-term Debt | -- | -98.98% | 0.10% | 0.14% | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 63.75% | 75.84% | 723.41% | 111.64% | -88.06% |
| Total Finance Division Other Current Liabilities | -10.48% | 12.21% | -18.92% | 18.22% | -15.28% |
| Total Other Current Liabilities | -10.48% | 12.21% | -18.92% | 18.22% | -15.28% |
| Total Current Liabilities | 5.63% | -12.15% | 9.79% | -2.05% | 50.04% |
|
|
|||||
| Total Current Liabilities | 5.63% | -12.15% | 9.79% | -2.05% | 50.04% |
| Long-Term Debt | 11.18% | 10.85% | -1.13% | -3.43% | -10.47% |
| Short-term Debt | -- | -98.98% | 0.10% | 0.14% | -- |
| Capital Leases | -4.41% | -3.89% | -3.61% | -3.38% | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 14.64% | 75.42% | 49.71% | -43.98% | -36.22% |
| Total Liabilities | 9.81% | 6.31% | 3.06% | -4.81% | 0.38% |
|
|
|||||
| Common Stock & APIC | 5.63% | 0.20% | 0.30% | 0.26% | 0.33% |
| Retained Earnings | -6.17% | -2.04% | -2.35% | -1.50% | -2.01% |
| Treasury Stock & Other | 127.41% | -3.19% | 21.81% | 9.83% | -60.36% |
| Total Common Equity | -8.79% | -12.70% | -16.05% | -10.68% | -16.52% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -8.79% | -12.70% | -16.05% | -10.68% | -16.52% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -8.79% | -12.70% | -16.05% | -10.68% | -16.52% |
|
|
|||||